Simulect - direct healthcare professional communication (DHPC)

basiliximab
DHPCHuman

Dutch is available via eTranslation, the European Commission's machine translation service.

Translate to Dutch | Important information about machine translation

Over

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documenten

Direct healthcare professional communication (DHPC) : SIMULECT (basiliximab): Do not use WFI ampoules co-packed with vials of sterile freeze-dried powder of Simulect 10mg and 20mg

English (EN) (230.52 kB - PDF)

Publicatiedatum: Laatst gewijzigd:
Bekijk

Key facts

Medicine name
Simulect
Active substance
basiliximab
Therapeutic area (MeSH)
  • Graft Rejection
  • Kidney Transplantation
Procedure number
EMEA/H/C/000207
DHPC type
Quality defect
Human ATC codes
L04AC02
Dissemination date

Share this page